Document is current
Any future updates will be listed below
-
Authors
Luzolo Khote, Flory
Raposo, Madalena
Maseko, Tafadzwa
Kanyamukenge, Deborah
Hachizovu, Sebastian
Makenga, Geofrey
Mukomena, Eric
Kakudji, Aimé
Mutombo, Augustin
Kikunda, Ghislain
Sombola, Jérémie
Maketa, Vivi
Nambozi, Michael
Duparc, Stephan
Rietveld, Hans
Alifrangis, Michael
Hansson, Helle
Wellmann, Louise
Ouare, Nathalie
Manyando, Christine
Van Geertruyden, JP
Baraka, Vito
Muhindo Mavoko, Hypolite
-
Funding
Funding for this research was provided by:
The European and Developing Countries Clinical Trials Partnerships (101103191 [HORIZON-JU-GH-EDCTP3-2022-01])
- License Information
-
More Information
Article History
Received: 31 January 2026
Accepted: 16 June 2026
First Online: 29 June 2026
Declarations
Ethics approval and consent to participate: The study protocol received approval from the National Ethics Committee of the DRC (approval reference: 502/CNES/BN/PMMF/2023 of January 22, 2024). Participation was voluntary, with informed consent obtained after a comprehensive explanation of the study by the research team. All patient information was kept confidential and accessible only to the research team.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.
